Researchers studying the serum of patients with osteoporosis found that Jintiange capsules inhibited the κB inhibitor signaling pathway by downregulating the overexpression of osteopontin, ultimately reducing MMP-3 expression. This evidence concerns the gene SPP1 and osteoporosis.